Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study
Agostino Bucalo(Sapienza University of Rome), Laura Ottini(Mount Sinai Hospital), Giuseppe Giannini(Istituto Pasteur), Ines Zanna(Piedmont Reference Center for Epidemiology and Cancer Prevention), Alessandro Bruselles(Istituto Superiore di Sanità), Siranoush Manoukian(Fondazione IRCCS Istituto Nazionale dei Tumori), Viviana Gismondi(University of Siena), Marco Montagna(Azienda Ospedale - Università Padova), Anna Coppa(Sapienza University of Rome), Marco Tartaglia(Bambino Gesù Children's Hospital), Laura Cortesi(Azienda Ospedaliero-Universitaria di Modena), Domenico Palli(Piedmont Reference Center for Epidemiology and Cancer Prevention), Carlo Capalbo(Sapienza University of Rome), Valentina Silvestri(Cancer Research UK Cambridge Center), Giulia Conti(Sapienza University of Rome), Virginia Valentini(Sapienza University of Rome), Bernardo Bonanni(European Institute of Oncology), Daniele Calistri(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Antonio Russo(University of Palermo), Paolo Peterlongo(IFOM), Paolo Radice(IFOM), Maria Grazia Tibiletti(University of Insubria), Livia Manzella(University of Catania), Alessandra Viel(Centro di Riferimento Oncologico), Daniela Turchetti(University of Bologna)
Cited by 19
Related Papers
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
Meat, Fish, and Colorectal Cancer Risk: The European Prospective Investigation into Cancer and Nutrition
|JNCI Journal of the National Cancer Institute|2005|865
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
|Nature Genetics|2007|702